Systematic review on the accuracy of positron emission tomography/computed tomography and positron emission tomography/magnetic resonance imaging in the management of ovarian cancer: Is functional information really needed?

Subapriya Suppiah; Wing Chang; Hasyma Hassan; Chalermrat Kaewput; Andi Asri; Fathinul Saad; Abdul Nordin; Sobhan Vinjamuri

doi:10.4103/wjnm.WJNM_31_17

World Journal of Nuclear Medicine, Table of Contents

CC BY-NC-ND 4.0 · World J Nucl Med 2017; 16(03): 176-185
DOI: 10.4103/wjnm.WJNM_31_17

Review article

Systematic review on the accuracy of positron emission tomography/computed tomography and positron emission tomography/magnetic resonance imaging in the management of ovarian cancer: Is functional information really needed?

Subapriya Suppiah

Centre for Diagnostic Nuclear Imaging, Universiti Putra Malaysia, Selangor

,

Wing Chang

Centre for Diagnostic Nuclear Imaging, Universiti Putra Malaysia, Selangor

,

Hasyma Hassan

¹Department of Imaging, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Selangor, Malaysia

,

Chalermrat Kaewput

²Department of Radiology, Division of Nuclear Medicine, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand

,

Andi Asri

³Department of Obstetrics and Gynaecology, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Selangor, Malaysia

,

Fathinul Saad

Centre for Diagnostic Nuclear Imaging, Universiti Putra Malaysia, Selangor

,

Abdul Nordin

¹Department of Imaging, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Selangor, Malaysia

,

Sobhan Vinjamuri

⁴Department of Nuclear Medicine, Royal Liverpool and Broadgreen University Hospitals, NHS Trusts, Liverpool

› Author Affiliations

Abstract

PDF Download

Ovarian cancer (OC) often presents at an advanced stage with frequent relapses despite optimal treatment; thus, accurate staging and restaging are required for improving treatment outcomes and prognostication. Conventionally, staging of OC is performed using contrast-enhanced computed tomography (CT). Nevertheless, recent advances in the field of hybrid imaging have made positron emission tomography/CT (PET/CT) and PET/magnetic resonance imaging (PET/MRI) as emerging potential noninvasive imaging tools for improved management of OC. Several studies have championed the role of PET/CT for the detection of recurrence and prognostication of OC. We provide a systematic review and meta-analysis of the latest publications regarding the role of molecular imaging in the management of OC. We retrieved 57 original research articles with one article having overlap in both diagnosis and staging; 10 articles (734 patients) regarding the role of PET/CT in diagnosis of OC; 12 articles (604 patients) regarding staging of OC; 22 studies (1429 patients) for detection of recurrence; and 13 articles for prognostication and assessment of treatment response. We calculated pooled sensitivity and specificity of PET/CT performance in various aspects of imaging of OC. We also discussed the emerging role of PET/MRI in the management of OC. We aim to give the readers and objective overview on the role of molecular imaging in the management of OC.

Keywords

Cancer - fluorodeoxyglucose - molecular imaging - ovary

PDF (873 kb)